Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • RonanC
    Junior Member
    • Jul 2012
    • 8

    Anyone else had enough of Life Technologies?

    I need to know if anyone else out there is as annoyed as I am about the whole 300/400 bp sequencing/OneTouch 2 fiasco?

    We were led to believe that we would be able to do 300/400 bp sequencing when we bought a PGM 9 months ago. Now we find out that in order to do 400 bp sequencing we will need to trade in our OneTouch instrument and buy a OneTouch 2 ($5K-$10K depending on when you buy it).

    But as if that weren't bad enough ..... Life Technologies released a 300 bp sequencing kit about 2-3 months ago. 300 bp sequencing didn't require a OneTouch 2 so we were able to do it on our OneTouch 1. We bought the kit and started doing the 300 bp sequencing......then......as soon as they announce that a OneTouch 2 is needed for 400 bp sequencing they discontinue the 300 bp sequencing kit. This essentially forces anyone who wants to do longer reads into buying a OneTouch 2.

    Seriously am I the only one out there who thinks this is a despicable business practice? Life Technologies should be ashamed of themselves. If we could go back in time 10 months we would absolutely NOT have bought a PGM. Unfortunately we are locked in now and that seems to be Life Technologies business model. Get you so far in that there is no turning back and you have to fork out the extra cash. Nice one.

    Thoughts?
  • ymc
    Senior Member
    • Mar 2010
    • 496

    #2
    Sorry to hear that. That's pretty much par for the course for this industry. Illumina discontinued many of its microarray chips to force you upgrade to their newer chip scanners. Illumina did give you almost a whole year's worth of advance notice though.

    Comment

    • Elcannibal
      Member
      • Jan 2012
      • 48

      #3
      Welcome to Invitrogen...

      Comment

      • jtackney
        Member
        • May 2012
        • 16

        #4
        I use the PGM and you have no idea how many conversations I have had with people concerning this exact same issue. They certainly seem to enjoy the bait and switch

        Now if only I didn't like their enzymes so much.....

        I don't think Illumina is much better though. It's the industry. They want to move fast because they fear being left behind. They just don't understand that they shouldn't abandon products when bringing out new ones. It just makes everyone angry and bitter, especially if that was not the deal hinted at by the sales force to make you buy the initial product in the first place.

        Comment

        • danwiththeplan
          Member
          • Sep 2011
          • 72

          #5
          Try hitting them up for a trade-in on your one-touch.

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
            by SEQadmin2


            Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

            The systematic characterization of the human proteome has
            ...
            07-20-2026, 11:48 AM
          • SEQadmin2
            Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
            by SEQadmin2



            Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
            ...
            07-09-2026, 11:10 AM
          • SEQadmin2
            Cancer Drug Resistance: The Lingering Barrier to Rising Survival
            by SEQadmin2



            Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

            There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
            07-08-2026, 05:17 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, 07-24-2026, 12:17 PM
          0 responses
          30 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-23-2026, 11:41 AM
          0 responses
          23 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-20-2026, 11:10 AM
          0 responses
          213 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-13-2026, 10:26 AM
          0 responses
          79 views
          0 reactions
          Last Post SEQadmin2  
          Working...